OGEN
Oragenics Inc
NYSE MKT: OGEN · HEALTHCARE · BIOTECHNOLOGY
$0.60
-1.21% today
Updated 2026-04-29
Market cap
$2.62M
P/E ratio
—
P/S ratio
89.28x
EPS (TTM)
$-4.56
Dividend yield
—
52W range
$1 – $10
Volume
0.3M
Oragenics Inc (OGEN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-243.90%
ROA
-101.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $66176.00 | $-2.94M | 100.00% | -4,475.67% | -4,436.23% |
| 2007 | $133088.00 | $-2.31M | 100.00% | -1,757.48% | -1,737.20% |
| 2008 | $233539.00 | $-6.02M | 93.64% | -2,590.15% | -2,578.58% |
| 2009 | $641285.00 | $-5.52M | 28.12% | -987.39% | -860.62% |
| 2010 | $1.31M | $-7.80M | 30.34% | -603.74% | -596.26% |
| 2011 | $1.44M | $-7.68M | 50.61% | -508.73% | -531.79% |
| 2012 | $1.33M | $-13.09M | 34.03% | -933.33% | -982.73% |
| 2013 | $1.03M | $-16.07M | 66.75% | -1,570.74% | -1,557.07% |
| 2014 | $939926.00 | $-5.79M | 60.68% | -618.82% | -615.95% |
| 2015 | $1.18M | $-11.71M | 59.02% | -990.82% | -995.83% |
| 2016 | $0.00 | $-7.01M | — | — | — |
| 2017 | $0.00 | $-6.73M | — | — | — |
| 2018 | $0.00 | $-9.91M | — | — | — |
| 2019 | $0.00 | $-15.57M | — | — | — |
| 2020 | $0.00 | $-26.43M | — | — | — |
| 2021 | $86987.00 | $-15.71M | 52.59% | -18,130.32% | -18,062.03% |
| 2022 | $131521.00 | $-14.29M | 66.04% | -10,964.61% | -10,863.96% |
| 2023 | $37653.00 | $-20.66M | -72.75% | -55,519.89% | -54,858.14% |
| 2024 | $0.00 | $-10.57M | — | — | — |
| 2025 | $0.00 | $-9.84M | — | — | — |